Autosomal recessive juvenile Parkinson disease 2 (PARK2 / PRKN-related Parkinson's): A Patient Guide

Autosomal recessive juvenile Parkinson disease 2, more commonly referred to as PRKN-related Parkinson’s, is a unique genetic form of the condition that differs significantly from the typical Parkinson’s disease diagnosed in older adults. While the historical name includes the term “juvenile,” it most often appears in early adulthood, with symptoms frequently beginning around the age of 30 ^[1]. It is caused by having biallelic pathogenic variants (two disease-causing changes) in the PRKN gene, which means the body cannot produce a functional version of the Parkin protein. This protein normally acts as a quality-control inspector, working with a partner called PINK1 to clear out damaged mitochondria—the power plants of the cell—through a recycling process known as mitophagy ^[2][3]. Without this clean-up crew, cellular waste accumulates, eventually leading to the loss of dopamine-producing neurons in the brain ^[4].

The way this condition moves through a person’s life tends to be slower on average than in other forms of Parkinson’s, allowing many people to maintain their independence and mobility for years ^[5]. Early signs often look different than the classic “resting tremor” many associate with the disease; instead, it frequently begins with dystonia, such as involuntary foot cramping or toes that curl during a walk ^[6]. Another hallmark is an excellent and often sustained response to levodopa, the primary medication used to treat motor symptoms ^[7]. While severe early cognitive decline is generally less common, other non-motor challenges like mood changes, sleep disorders, and fatigue can be a significant part of daily life and require consistent attention from a care team ^[5][8].

Understanding a PRKN diagnosis provides a clearer roadmap for your care. Because the motor progression is generally slower and the response to treatment is often robust, the goal of care is to proactively manage symptoms so they remain in the background of an active life. By combining effective medication strategies with consistent exercise and the support of a multidisciplinary team, you can focus on long-term daily function and the many life milestones that lie ahead ^[5][7]. Although there is currently no PRKN-specific disease-modifying treatment, the biological clarity of a PRKN diagnosis helps you and your doctors better understand your condition and tailor your symptom-based treatment to your needs ^[4].